Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.30p
   
  • Change Today:
      0.15p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 623.91m
  • Volume: 898,650
  • Market Cap: £26.83m
  • RiskGrade: 328
  • Beta: 0.01

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
16-Apr-18 Berenberg Bank Buy 147.00p 1,200.00p 1,200.00p Reiteration
23-Mar-18 Northland Capital Partners Buy 125.50p - 181.00p Reiteration
21-Dec-17 FinnCap Buy 150.00p 237.00p 237.00p Reiteration
30-Apr-15 Panmure Gordon Buy - 150.00p 150.00p Reiteration
12-Mar-12 Peel Hunt Limited Sell - - 50.00p New Coverage
21-Nov-11 Sanlam Securities Buy - - 323.00p New Coverage
06-Dec-10 Espirito Santo Execution Buy - 200.00p - Reiteration
30-Sep-10 Singer Capital Markets Buy - - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Immupharma Market Data

Currency UK Pounds
Share Price 4.30p
Change Today 0.15p
% Change 3.61 %
52 Week High 17.60
52 Week Low 1.50
Volume 898,650
Shares Issued 623.91m
Market Cap £26.83m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 11-May-2026

Time Volume / Share Price
13:47 30,000 @ 4.30p
13:43 33,165 @ 4.22p
13:38 6,825 @ 4.40p
13:33 32,032 @ 4.38p
13:22 126 @ 4.79p

Immupharma Key Personnel

CFO Ashley Clarke

Top of Page